Patent · US Active

Arylpiperazine derivatives and methods of utilizing same

US8980883B2 · kind B2 · utility

1Cited by

1References

20Claims

0Family size

Assignee

REVIVA PHARMACEUTICALS, INC. · US

Inventors

Laxminarayan Bhat · Bengaluru, IN
Prabhu Prasad Mohapatra · San Jose, US
Kouacou Adiey · San Jose, US

Key dates

Filing date	Sep 17, 2014
Grant date	Mar 17, 2015
Priority date	—
Expiry date	Sep 17, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.